249 related articles for article (PubMed ID: 27167337)
1. OTUB1-catalyzed deubiquitination of FOXM1 facilitates tumor progression and predicts a poor prognosis in ovarian cancer.
Wang Y; Zhou X; Xu M; Weng W; Zhang Q; Yang Y; Wei P; Du X
Oncotarget; 2016 Jun; 7(24):36681-36697. PubMed ID: 27167337
[TBL] [Abstract][Full Text] [Related]
2. OTUB1 inhibits the ubiquitination and degradation of FOXM1 in breast cancer and epirubicin resistance.
Karunarathna U; Kongsema M; Zona S; Gong C; Cabrera E; Gomes AR; Man EP; Khongkow P; Tsang JW; Khoo US; Medema RH; Freire R; Lam EW
Oncogene; 2016 Mar; 35(11):1433-44. PubMed ID: 26148240
[TBL] [Abstract][Full Text] [Related]
3. OTUB1-mediated deubiquitination of FOXM1 up-regulates ECT-2 to promote tumor progression in renal cell carcinoma.
Zhou K; Mai H; Zheng S; Cai W; Yang X; Chen Z; Zhan B
Cell Biosci; 2020; 10():50. PubMed ID: 32257108
[TBL] [Abstract][Full Text] [Related]
4. FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients.
Tassi RA; Todeschini P; Siegel ER; Calza S; Cappella P; Ardighieri L; Cadei M; Bugatti M; Romani C; Bandiera E; Zanotti L; Tassone L; Guarino D; Santonocito C; Capoluongo ED; Beltrame L; Erba E; Marchini S; D'Incalci M; Donzelli C; Santin AD; Pecorelli S; Sartori E; Bignotti E; Odicino F; Ravaggi A
J Exp Clin Cancer Res; 2017 May; 36(1):63. PubMed ID: 28482906
[TBL] [Abstract][Full Text] [Related]
5. TRIM24 aggravates the progression of ovarian cancer through negatively regulating FOXM1 level.
Zhou HE; Pan SS; Han H
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10647-10656. PubMed ID: 31858531
[TBL] [Abstract][Full Text] [Related]
6. The non-coding RNA OTUB1-isoform2 promotes ovarian tumour progression and predicts poor prognosis.
Wang S; Ning Y; Wei P; Cai D; Lu L; Li J; Wang Y
J Cell Mol Med; 2018 Oct; 22(10):4794-4806. PubMed ID: 30044532
[TBL] [Abstract][Full Text] [Related]
7. OTUB1 promotes esophageal squamous cell carcinoma metastasis through modulating Snail stability.
Zhou H; Liu Y; Zhu R; Ding F; Cao X; Lin D; Liu Z
Oncogene; 2018 Jun; 37(25):3356-3368. PubMed ID: 29559747
[TBL] [Abstract][Full Text] [Related]
8. VprBP/DCAF1 Regulates the Degradation and Nonproteolytic Activation of the Cell Cycle Transcription Factor FoxM1.
Wang X; Arceci A; Bird K; Mills CA; Choudhury R; Kernan JL; Zhou C; Bae-Jump V; Bowers A; Emanuele MJ
Mol Cell Biol; 2017 Jul; 37(13):. PubMed ID: 28416635
[TBL] [Abstract][Full Text] [Related]
9. DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-β/SMAD4 signaling.
Chan DW; Hui WW; Wang JJ; Yung MM; Hui LM; Qin Y; Liang RR; Leung TH; Xu D; Chan KK; Yao KM; Tsang BK; Ngan HY
Oncogene; 2017 Mar; 36(10):1404-1416. PubMed ID: 27593933
[TBL] [Abstract][Full Text] [Related]
10. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein.
Li Y; Sun XX; Elferich J; Shinde U; David LL; Dai MS
J Biol Chem; 2014 Feb; 289(8):5097-108. PubMed ID: 24403071
[TBL] [Abstract][Full Text] [Related]
11. Mutant p53 driven-LINC00857, a protein scaffold between FOXM1 and deubiquitinase OTUB1, promotes the metastasis of pancreatic cancer.
Zhang W; Qian W; Gu J; Gong M; Zhang W; Zhang S; Zhou C; Jiang Z; Jiang J; Han L; Wang X; Wu Z; Ma Q; Wang Z
Cancer Lett; 2023 Jan; 552():215976. PubMed ID: 36272615
[TBL] [Abstract][Full Text] [Related]
12. FoxM1 promotes the migration of ovarian cancer cell through KRT5 and KRT7.
Zhang Z; Tu K; Liu F; Liang M; Yu K; Wang Y; Luo Y; Yang B; Qin Y; He D; Jiang G; Huang O; Zou Y
Gene; 2020 Oct; 757():144947. PubMed ID: 32659254
[TBL] [Abstract][Full Text] [Related]
13. FOXM1 promotes reprogramming of glucose metabolism in epithelial ovarian cancer cells via activation of GLUT1 and HK2 transcription.
Wang Y; Yun Y; Wu B; Wen L; Wen M; Yang H; Zhao L; Liu W; Huang S; Wen N; Li Y
Oncotarget; 2016 Jul; 7(30):47985-47997. PubMed ID: 27351131
[TBL] [Abstract][Full Text] [Related]
14. Co-regulation and function of
Barger CJ; Chee L; Albahrani M; Munoz-Trujillo C; Boghean L; Branick C; Odunsi K; Drapkin R; Zou L; Karpf AR
Elife; 2021 Apr; 10():. PubMed ID: 33890574
[TBL] [Abstract][Full Text] [Related]
15. Deubiquitination of MYC by OTUB1 contributes to HK2 mediated glycolysis and breast tumorigenesis.
Han X; Ren C; Lu C; Qiao P; Yang T; Yu Z
Cell Death Differ; 2022 Sep; 29(9):1864-1873. PubMed ID: 35296795
[TBL] [Abstract][Full Text] [Related]
16. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer.
Fan Q; Cai Q; Xu Y
Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of the Non-Coding RNA OTUB1-isoform 2 Contributes to Gastric Cancer Cell Proliferation and Invasion and Predicts Poor Gastric Cancer Prognosis.
Wang YQ; Zhang QY; Weng WW; Wu Y; Yang YS; Shen C; Chen XC; Wang L; Liu KJ; Xu MD; Sheng WQ
Int J Biol Sci; 2016; 12(5):545-57. PubMed ID: 27019636
[TBL] [Abstract][Full Text] [Related]
18. OTUB1 facilitates bladder cancer progression by stabilizing ATF6 in response to endoplasmic reticulum stress.
Zhang HH; Li C; Ren JW; Liu L; Du XH; Gao J; Liu T; Li SZ
Cancer Sci; 2021 Jun; 112(6):2199-2209. PubMed ID: 33686769
[TBL] [Abstract][Full Text] [Related]
19. PCNA-associated factor P15
Jin C; Liu Z; Li Y; Bu H; Wang Y; Xu Y; Qiu C; Yan S; Yuan C; Li R; Diao N; Zhang Z; Wang X; Liu L; Kong B
Int J Cancer; 2018 Dec; 143(11):2973-2984. PubMed ID: 30129654
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation-mediated degradation of FBXL2 stabilizes FOXM1 to induce cancer progression.
Ueda Y; Moriwaki K; Takeuchi T; Higuchi K; Asahi M
Biochem Biophys Res Commun; 2020 Jan; 521(3):632-638. PubMed ID: 31679690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]